BRILZEOND Trademark

Trademark Overview

On Tuesday, January 26, 2021, a trademark application was filed for BRILZEOND with the United States Patent and Trademark Office. The USPTO has given the BRILZEOND trademark a serial number of 90489161. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, April 3, 2024. This trademark is owned by Principia Biopharma Inc.. The BRILZEOND trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of immune-mediated, autoimmune, inflammatory, respiratory, and rare diseases and disorders; pharmaceutical preparations for preventing and treating diseases and disorders of the skin and blood; pharmaceutical preparations for preventing and treating lesions and tumors
brilzeond

General Information

Serial Number90489161
Word MarkBRILZEOND
Filing DateTuesday, January 26, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, April 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 21, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of immune-mediated, autoimmune, inflammatory, respiratory, and rare diseases and disorders; pharmaceutical preparations for preventing and treating diseases and disorders of the skin and blood; pharmaceutical preparations for preventing and treating lesions and tumors

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 27, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePrincipia Biopharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807
Party NamePrincipia Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Thursday, April 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 3, 2024SOU EXTENSION 5 GRANTED
Wednesday, April 3, 2024SOU EXTENSION 5 FILED
Wednesday, April 3, 2024SOU TEAS EXTENSION RECEIVED
Saturday, September 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 28, 2023SOU EXTENSION 4 GRANTED
Thursday, September 28, 2023SOU EXTENSION 4 FILED
Thursday, September 28, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 22, 2023SOU EXTENSION 3 GRANTED
Wednesday, March 22, 2023SOU EXTENSION 3 FILED
Wednesday, March 22, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 10, 2022SOU EXTENSION 2 GRANTED
Monday, October 10, 2022SOU EXTENSION 2 FILED
Monday, October 10, 2022SOU TEAS EXTENSION RECEIVED
Saturday, April 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 14, 2022SOU EXTENSION 1 GRANTED
Thursday, April 14, 2022SOU EXTENSION 1 FILED
Thursday, April 14, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 21, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 18, 2021ELECTRONIC RECORD REVIEW COMPLETE
Friday, August 13, 2021ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, August 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 12, 2021ASSIGNED TO EXAMINER
Tuesday, April 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 29, 2021NEW APPLICATION ENTERED

Related Keywords

brilzeond pharmaceutical preparations diseases preventing disorders treating blood tumors lesions skin